| Issue 44 – Nov. 22, 2013 |
New pressures notwithstanding, being a cancer center director is still a dream job, two of the nation’s newest cancer center directors said.
20131203_14
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
FDA has granted an accelerated approval to RP1 (vusolimogene oderparepvec) following the agency’s Cellular, Tissue, and Gene Therapies Advisory Committee’s 10:3 vote in support of the biologic in combination with nivolumab for the treatment of advanced melanoma in patients who have progressed on prior anti-PD-1 therapy.
U.S. News & World Report has been publishing the best cancer hospitals rankings for 37 years, but this year is different.
AÂ patient recently asked me a question I suspect many thoracic surgeons will soon be hearing.
When it comes to harnessing artificial intelligence for cancer breakthroughs, Johns Hopkins researchers Alex Szalay, PhD, and Janis Taube, MD, MSc, believe the future begins with data—lots of it.
The Senate has released its version of a 2027 continuing resolution that would fund the U.S. government through Dec. 11.Â
